Research Ethics: Constitutional Dimension under Indian Law

1. Introduction

Research involving human beings creates a fundamental legal question:

How far may the interests of scientific advancement justify interference with the body, privacy, liberty, dignity and autonomy of an individual?

The constitutional answer in India is that scientific research is a legitimate and socially valuable objective, but it cannot be pursued by treating human participants merely as instruments for producing knowledge.

The Indian constitutional framework therefore requires a balance between:

• scientific and medical advancement;
• public health;
• individual autonomy;
• bodily integrity;
• privacy;
• dignity;
• equality;
• protection of vulnerable persons; and
• freedom from exploitation.

The ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017 expressly state that research must protect participants' dignity and well-being and must not treat human beings merely as means for benefiting others. They cover biomedical as well as social and behavioural research for health, including informed consent, vulnerability, biological materials, biobanks and datasets.

2. Constitutional provisions relevant to research ethics

There is no single constitutional article called the “right to ethical research.”

Instead, research ethics derives from several fundamental rights and constitutional principles.

The most important provision is undoubtedly Article 21.

3. Article 21: the constitutional foundation

Article 21 provides:

“No person shall be deprived of his life or personal liberty except according to procedure established by law.”

The Supreme Court has transformed Article 21 from a narrow protection against unlawful deprivation of liberty into a broad guarantee of life with dignity, bodily autonomy, privacy and decisional freedom.

This is crucial for research.

A human participant does not surrender constitutional rights simply because he or she agrees to participate in a study.

The participant remains a constitutional rights-holder.

4. Bodily autonomy

Research frequently involves physical intervention:

• clinical trials;
• vaccine trials;
• surgery;
• administration of experimental drugs;
• genetic testing;
• stem-cell interventions;
• collection of blood or tissue;
• reproductive research;
• neurological research.

The principle of bodily autonomy means that the individual's body cannot ordinarily be used for research without legally and ethically valid authorization.

The Supreme Court's decision in Samira Kohli v. Dr Prabha Manchanda, (2008) 2 SCC 1, is a leading authority on consent and bodily autonomy.

The Court held that valid consent requires:

1. capacity and competence;
2. voluntariness; and
3. adequate information about the nature of the procedure.

The Court also emphasized that consent for one procedure does not automatically authorize a different procedure.

Although Samira Kohli concerned medical treatment rather than a research trial, its doctrine is extremely important for research ethics.

5. Samira Kohli: informed consent as constitutional/ethical principle

In Samira Kohli, the patient consented to diagnostic laparoscopy, but a much more extensive operation involving removal of reproductive organs was performed.

The Supreme Court rejected the argument that consent to the initial procedure authorized the additional radical surgery.

The Court explained that consent must be real and valid and that the patient must receive sufficient information to make a meaningful decision.

The Court identified information concerning:

• nature of the procedure;
• purpose;
• benefits;
• effects;
• available alternatives;
• substantial risks; and
• consequences of refusing treatment.

Application to research

The research setting arguably demands an even more careful approach because the participant may not personally receive therapeutic benefit.

For example, a research participant should know:

“This is research, not established treatment.”

That distinction is fundamental.

6. The 2026 Supreme Court breakthrough: Yash Charitable Trust v. Union of India

The most important contemporary authority is:

Yash Charitable Trust & Ors. v. Union of India & Ors., 2026 INSC 96, decided 30 January 2026.

The case concerned the use of stem-cell therapy for autism spectrum disorder (ASD) and whether such interventions could be offered as ordinary medical treatment or only within an approved research/clinical-trial framework.

The Supreme Court held that therapeutic use of stem cells for ASD, given the scientific position considered by the Court, could not be offered as ordinary clinical treatment outside an approved and monitored clinical trial/research setting.

This case is extraordinarily important for research ethics because it connects:

scientific validity + informed consent + patient autonomy + research regulation + constitutional values.

7. Consent does not make scientifically invalid research lawful

One of the most significant propositions in Yash Charitable Trust is that consent is not an unlimited waiver of legal and ethical safeguards.

The Court explained that consent is a method of exercising patient autonomy, but autonomy does not give a person an unlimited right to demand a scientifically unvalidated or ethically impermissible medical procedure.

In other words:

“I consent” does not automatically mean “the researcher may lawfully do anything to me.”

This distinction is fundamental.

A participant may voluntarily agree to something, but the State and ethics-review system may still prohibit the intervention because:

• the evidence is inadequate;
• the risk is disproportionate;
• the intervention is scientifically unvalidated;
• there is therapeutic misconception;
• the procedure bypasses clinical-trial safeguards; or
• vulnerable participants may be exploited.

8. Therapeutic misconception

Yash Charitable Trust gives particular importance to therapeutic misconception.

This occurs when a research participant believes that the primary purpose of an experimental intervention is to provide personal medical treatment, when the actual primary purpose is to generate generalizable knowledge.

The Supreme Court observed that novel treatments with insufficient scientific support can create precisely this misconception.

Example

Suppose a clinic tells parents:

“We have a revolutionary stem-cell treatment for your child.”

The parents pay for the procedure believing that it is established therapy.

If the intervention is actually experimental research, the participant has not necessarily made a genuinely informed decision merely because a form was signed.

The ethical problem is therefore not simply absence of a signature.

It is misunderstanding of the nature of the intervention itself.

9. Higher standard of consent in experimental research

The Supreme Court in Yash Charitable Trust recommended a rights-based protective framework for experimental therapies.

It specifically referred to the need for:

• patient disclosure;
• consent protocols;
• a higher standard of voluntary free informed consent for unproven therapies;
• protection of research participants;
• compensation in cases of injury or death; and
• prohibition on treating participation in experimental treatment as ordinary commercial treatment. 

This represents a significant development in Indian research-ethics jurisprudence.

10. Privacy: K.S. Puttaswamy v. Union of India

The constitutional dimension of research ethics becomes even stronger after the Supreme Court's landmark privacy decision:

Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1.

The nine-judge Bench recognized privacy as a fundamental right arising primarily from Article 21 and other constitutional freedoms.

For research, privacy is particularly important because researchers may collect:

• medical records;
• genetic information;
• photographs;
• DNA;
• biological samples;
• psychiatric information;
• sexual-health information;
• reproductive information;
• family histories;
• biometric information; and
• identifiable datasets.

Such information can potentially reveal intimate aspects of an individual's life.

Consequently, research ethics must include:

data minimization + confidentiality + controlled access + legitimate purpose + informed authorization.

11. Privacy is more than secrecy

Constitutional privacy has several dimensions.

Informational privacy

The participant should have control, subject to law, over the collection and use of personal information.

Decisional privacy

The individual has a sphere in which personal decisions should remain free from unjustified State interference.

Bodily privacy

The body itself is protected against unauthorized intrusion.

These concepts reinforce research ethics.

For example, a researcher cannot simply say:

“The participant signed the consent form, therefore privacy no longer matters.”

Consent to participate in Study A does not necessarily authorize unrestricted future use of identifiable information for Studies B, C and D.

12. Selvi v. State of Karnataka: involuntary scientific techniques

Another important case is:

Selvi v. State of Karnataka, (2010) 7 SCC 263.

The Supreme Court considered involuntary use of techniques such as:

• narcoanalysis;
• polygraph examinations; and
• Brain Electrical Activation Profile (BEAP) tests.

The Court considered both Article 20(3) and Article 21, including personal liberty.

The principle is highly relevant to research ethics:

Scientific technology does not automatically override constitutional autonomy.

Even where scientific techniques may provide potentially valuable information, compulsory application raises constitutional questions concerning:

• bodily integrity;
• mental privacy;
• personal liberty;
• self-incrimination;
• voluntariness.

This becomes increasingly important with modern neurotechnology and genetic research.

13. Article 14: equality and non-discrimination in research

Article 14 requires equality before the law and equal protection of the laws.

Research ethics therefore requires careful attention to who bears the risks of research and who receives its benefits.

A study may become constitutionally problematic if vulnerable populations are disproportionately recruited merely because they are easier to control.

Examples include:

• prisoners;
• institutionalized persons;
• economically disadvantaged groups;
• children;
• persons with disabilities;
• persons with diminished decision-making capacity;
• marginalized communities.

The constitutional problem is not merely discrimination in the abstract.

It is also structural exploitation.

14. Vulnerable participants

The ICMR 2017 Guidelines devote particular attention to vulnerable persons and populations.

The Guidelines recognize that research participants must be treated in a manner consistent with:

• dignity;
• well-being;
• fair treatment;
• transparency; and
• protection from exploitation. 

They specifically expanded their treatment of:

• informed consent;
• vulnerability;
• biological materials;
• datasets;
• biobanking; and
• responsible conduct of research. 

Thus, constitutional equality and research ethics reinforce each other.

15. Article 19 and academic freedom

Article 19 protects freedom of speech and expression.

Academic research, publication, discussion and dissemination of scientific findings can therefore fall within the constitutional protection of expressive freedom.

But academic freedom is not absolute.

Research cannot be defended simply as “academic freedom” where it involves:

• unlawful experimentation;
• unauthorized use of human subjects;
• fraud;
• falsification;
• serious threats to public health;
• unlawful collection of personal data; or
• violation of fundamental rights.

Thus:

Academic freedom protects inquiry; it does not create a constitutional licence to violate human dignity.

16. Article 51A(h): scientific temper

Article 51A(h) requires citizens to develop:

scientific temper, humanism and the spirit of inquiry and reform.

This provision is especially interesting in research-ethics analysis.

Scientific temper has two sides:

Positive dimension

Society should encourage:

• scientific investigation;
• evidence;
• rationality;
• innovation;
• critical inquiry.

Ethical dimension

Scientific inquiry should not become an excuse for:

• pseudoscience;
• unsupported medical claims;
• exploitation;
• concealment of risks;
• manipulation of participants.

The Yash Charitable Trust judgment strongly reflects this relationship between scientific validity and ethical legitimacy.

17. Article 47: public health

Article 47 directs the State to regard improvement of public health as among its primary duties.

This creates an important constitutional justification for biomedical research.

Research may serve Article 47 by producing:

• vaccines;
• medicines;
• disease-prevention strategies;
• public-health interventions;
• epidemiological knowledge.

But Article 47 cannot override Article 21.

The constitutional balance is therefore:

public-health benefit ↔ individual rights.

The State cannot simply argue:

“This research benefits society, therefore individual participants may be exposed to unacceptable risks.”

18. Research ethics committees

Ethics Committees/Institutional Ethics Committees are central to this constitutional structure.

The purpose is not merely administrative approval.

An Ethics Committee functions as a protective institutional mechanism between scientific research and the individual participant.

It should examine matters including:

• scientific validity;
• risk-benefit ratio;
• informed consent;
• confidentiality;
• vulnerability;
• compensation;
• participant selection;
• privacy;
• conflict of interest;
• post-trial responsibilities.

The ICMR continues to maintain extensive ethical guidance, including its 2017 National Ethical Guidelines, 2023 guidance for multicentre research, 2024 guidance on leftover de-identified samples, and 2026 operational guidelines for single ethics review of multicentre research.

19. Yash Charitable Trust: legal significance of ICMR guidelines

The 2026 Supreme Court judgment is especially important concerning the legal status of ethical guidelines.

The Court recognized that ICMR materials can provide an authoritative scientific and ethical baseline for evaluating whether medical practice conforms to contemporary professional standards.

More importantly, in the particular regulatory context considered by the Court, the New Drugs and Clinical Trials Rules, 2019 and applicable medical regulations gave the relevant ICMR requirements legal significance.

Therefore, it is important not to make the overbroad statement:

“All ICMR guidelines are automatically statutes.”

That is incorrect.

The legal force of a particular guideline depends on its statutory/regulatory basis and the circumstances in which it is being applied.

20. Research versus treatment

This distinction is fundamental.

Ordinary medical treatment

Primary purpose:

benefit the individual patient.

Research

Primary purpose:

produce generalizable knowledge.

Clinical research

May combine both objectives, but the research purpose must remain transparent.

A researcher cannot disguise experimentation as ordinary treatment.

This is precisely why Yash Charitable Trust treated therapeutic misconception as a serious ethical problem.

21. Compensation for research-related injury

A constitutional research framework must also address what happens when participants are injured.

The Supreme Court in Yash Charitable Trust emphasized the need for protection of research participants and recommended an immediate/interim compensation mechanism for injury or death in experimental clinical research.

This reflects an important principle:

A participant who bears the risk of generating socially useful scientific knowledge should not be left without an effective remedy when the research causes legally compensable harm.

22. Common Cause and dignity

The Supreme Court's jurisprudence concerning end-of-life decisions is also relevant.

In Common Cause v. Union of India, the Court recognized the constitutional significance of dignity, autonomy and privacy under Article 21 in relation to end-of-life decisions.

The later 2026 decision in Harish Rana v. Union of India summarized the position from Common Cause, noting that the right to live with dignity includes a right to die with dignity and that advance medical directives are grounded in constitutional values of liberty, dignity and individual privacy.

Although this is not a research case, the constitutional principle is relevant:

The individual has a protected sphere of decision-making concerning his or her own body and medical choices.

23. Constitutional principles emerging from the case law

The Indian cases collectively support the following principles:

Principle 1 — Human beings are not merely research instruments

Scientific advancement cannot justify treating participants merely as means.

Principle 2 — Consent must be meaningful

A signature is not sufficient if the participant lacks adequate information.

Principle 3 — Consent must be voluntary

Coercion, undue influence or exploitation undermines ethical consent.

Principle 4 — Consent requires capacity

The researcher must consider whether the participant can understand and make the decision.

Principle 5 — Privacy protects research participants

Medical and genetic information can fall within constitutionally protected privacy.

Principle 6 — Autonomy has limits

A participant's consent does not authorize an otherwise unlawful or scientifically impermissible intervention.

Principle 7 — Vulnerable groups require additional safeguards

Equality does not always mean identical treatment; sometimes additional protection is constitutionally necessary.

Principle 8 — Scientific validity is itself an ethical issue

Research cannot ethically be justified merely because participants consent.

Principle 9 — Research injury requires effective remedies

The legal system must provide meaningful protection and compensation where applicable.

Principle 10 — Ethics Committees are rights-protective institutions

Ethical review helps operationalize constitutional protections.

24. Major case-law table

25. The constitutional test for ethical research

A useful legal test can be formulated as follows.

Before human research is undertaken, ask:

1. Legality

Is the research authorized by the applicable legislation and regulatory framework?

2. Scientific validity

Is the research scientifically justified?

3. Necessity

Is human participation genuinely necessary?

4. Risk-benefit proportionality

Are foreseeable risks justified by potential scientific/social benefits?

5. Autonomy

Has the participant made a genuinely voluntary decision?

6. Informed consent

Has adequate information been disclosed?

7. Privacy

Are personal information and biological materials adequately protected?

8. Equality

Are participants selected fairly?

9. Vulnerability

Are additional safeguards required?

10. Independent review

Has the project received appropriate Ethics Committee approval?

11. Compensation

Are arrangements in place for research-related injury?

12. Transparency

Are funding, conflicts of interest and the experimental nature of the intervention disclosed?

This framework brings Articles 14 and 21, statutory regulation, ICMR guidelines and bioethical principles together.

26. The deeper constitutional philosophy

The constitutional dimension of research ethics can ultimately be reduced to a conflict between two values:

Collective interest

“Society needs scientific knowledge.”

versus

Individual rights

“No person should be sacrificed merely as a means of producing that knowledge.”

The ICMR Guidelines expressly adopt the latter protection by stating that participants should not become merely a means for the betterment of others and should be treated consistently with dignity, well-being, fair treatment and transparency.

The Supreme Court's 2026 decision in Yash Charitable Trust brings this principle into particularly sharp focus: scientific progress is constitutionally valuable, but scientific progress must occur within a framework that protects autonomy, informed consent, safety and human dignity.

Conclusion

Indian constitutional law does not create a freestanding fundamental right called “research ethics.” Rather, ethical research requirements emerge from the combined operation of Articles 14, 19 and 21, the constitutional commitment to scientific inquiry under Article 51A(h), the public-health objective under Article 47, statutory clinical-trial regulation, and ICMR ethical standards.

The decisive constitutional principle is human dignity.

The trajectory from Samira Kohli to Puttaswamy and Common Cause, culminating most recently in Yash Charitable Trust v. Union of India (2026), demonstrates an increasingly sophisticated legal position: a person's voluntary participation in research is necessary, but consent alone is not sufficient. The research itself must satisfy scientific, legal and ethical requirements.

For academic research, the 2026 Yash Charitable Trust judgment should now be treated as the central Indian case on the constitutional and legal relationship between experimental treatment, research ethics, informed consent and patient autonomy.